Health
Medicare Advantage enrollment expected to fall in 2026 as insurers cut back on unprofitable plans
Advocates hold signs during a news conference on Medicare Advantage plans in front of the U.S. Capitol on July 25, 2023 in Washington, DC. Alex Wong | Getty Images News | Getty Images Medicare Advantage enrollment is poised to fall for the first time in nearly two decades, according to the Centers for Medicare and […]
Read More
CDC takes down more than a dozen webpages on sexual and gender identity, health equity
A sign for the CDC sits outside of their facility at the Centers for Disease Control and Prevention Roybal campus in Atlanta, Georgia, U.S., May 30, 2025. Megan Varner | Reuters More than a dozen pages on the Centers for Disease Control and Prevention website related to sexual and gender identity, health equity, and other […]
Read More
We’re buying the dip in a health and life sciences stock that has gone down enough
We’re buying 20 more shares of Danaher at roughly $180 each. Following Thursday’s trade, Jim Cramer’s Charitable Trust will own 470 shares of DHR, increasing its weighting to about 2.31% from about 2.22%. While Danaher has certainly been one of a handful of problematic stocks in the portfolio, we are stepping into the name here, […]
Read More
Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial
The Roche Holding AG headquarters on April 11, 2025, in Basel, Switzerland. Sedat Suna | Getty Images News | Getty Images Swiss pharmaceutical firm Roche is targeting becoming a top three obesity player globally, posing a potential rival to heavyweights Novo Nordisk and Eli Lilly as it advances one of its experimental weight-loss drugs to […]
Read More
Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs
A rendering of Eli Lilly’s manufacturing facility in Houston, Texas. Courtesy: Eli Lilly Eli Lilly on Tuesday said it will spend $6.5 billion to build a manufacturing facility in Houston, Texas, to boost production of the company’s pipeline of so-called small molecule drugs, including its closely watched experimental obesity pill. It is the second in […]
Read More
Trump admin draws unproven link between autism and Tylenol ingredient use during pregnancy
In this photo illustration, Tylenol caplets are displayed on Sept. 22, 2025 in San Anselmo, California. Justin Sullivan | Getty Images The Trump administration on Monday drew an unproven link between autism and pregnant women’s use of acetaminophen, the active ingredient in one of the world’s most common over-the-counter pain relievers, Kenvue’s Tylenol. President Donald […]
Read More
RFK Jr.’s vaccine panel weakens Covid shot recommendations, calling it an individual decision
Members of the Advisory Committee on Immunization Practices (ACIP) listen to a presentation about COVID-19 (coronavirus disease) during an Advisory Committee on Immunization Practices (ACIP) meeting at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, U.S., Sept. 19, 2025. Alyssa Pointer | Reuters Health and Human Services Secretary Robert F. Kennedy Jr.’s […]
Read More
RFK Jr.’s vaccine panel postpones vote on whether to delay babies’ first hepatitis B shot
Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine panel on Friday postponed a vote on whether to delay the first dose of the hepatitis B shot from birth to at least one month for most babies born in the U.S. The decision means that the committee’s current recommendation – that all infants […]
Read More
Covid shot access, coverage at stake as RFK Jr.’s hand-picked vaccine panel convenes
Ruth Jones, immunization nurse, holds a Pfizer-BioNTech COVID-19 vaccine (brand name: Comirnaty) at Borinquen Health Care Center in Miami, Florida, on May 29, 2025. Joe Raedle | Getty Images Covid shot access and coverage in the U.S. hang in the balance as an influential government vaccine panel hand-picked by Health and Human Services Secretary Robert […]
Read More
Novo Nordisk shares pop 5% after Wegovy pill trial shows ‘significant’ weight reduction
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk said Wednesday that late-stage trial results […]
Read More